|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.83 USD | +0.17% |
|
-5.16% | -20.50% |
| Capitalization | 2.37B 2.02B 1.86B 1.76B 3.24B 223B 3.31B 21.81B 8.59B 107B 8.9B 8.72B 378B | P/E ratio 2026 * |
-13.1x | P/E ratio 2027 * | -15.9x |
|---|---|---|---|---|---|
| Enterprise value | 2.23B 1.91B 1.75B 1.65B 3.05B 210B 3.12B 20.53B 8.09B 100B 8.38B 8.21B 356B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 18.7x |
| Free-Float |
88.44% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Mineralys Therapeutics, Inc.
| 1 day | +0.24% | ||
| 1 week | -5.16% | ||
| Current month | +6.50% | ||
| 1 month | +21.99% | ||
| 3 months | -15.84% | ||
| 6 months | -31.37% | ||
| Current year | -20.50% |
| 1 week | 27.67 | 31.48 | |
| 1 month | 22.42 | 31.48 | |
| Current year | 22.42 | 37.7 | |
| 1 year | 12.59 | 47.65 | |
| 3 years | 5.85 | 47.65 | |
| 5 years | 5.85 | 47.65 | |
| 10 years | 5.85 | 47.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Congleton
CEO | Chief Executive Officer | 62 | 2020-10-31 |
Adam Levy
DFI | Director of Finance/CFO | 48 | 2022-02-28 |
Tiffany Burt
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 58 | 2021-01-31 | |
Glenn Sblendorio
CHM | Chairman | 70 | - |
Daphne Karydas
BRD | Director/Board Member | 51 | 2023-09-12 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.17% | -5.16% | +118.40% | +110.58% | 2.37B | ||
| -0.55% | -4.80% | -7.47% | -12.17% | 45.74B | ||
| -0.33% | -2.84% | +22.97% | +20.77% | 34.63B | ||
| -4.83% | -7.07% | +284.59% | +515.54% | 31.32B | ||
| -0.26% | -1.71% | +21.90% | -13.76% | 29.49B | ||
| +0.49% | +2.46% | +34.79% | +32.44% | 28.78B | ||
| -4.43% | -4.99% | +44.32% | +187.89% | 14.85B | ||
| -1.41% | -1.97% | +80.08% | +171.46% | 14.7B | ||
| -9.69% | -8.53% | +26.37% | +2.45% | 14.34B | ||
| +4.58% | +0.21% | +3,841.64% | +4,135.60% | 14.04B | ||
| Average | -1.55% | -0.48% | +446.76% | +515.08% | 23.03B | |
| Weighted average by Cap. | -1.44% | -0.85% | +292.95% | +349.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 118M 101M 92.41M 87.41M 161M 11.07B 165M 1.09B 428M 5.3B 443M 434M 18.82B |
| Net income | -181M -155M -142M -134M -248M -17B -253M -1.67B -656M -8.14B -680M -666M -28.89B | -156M -133M -122M -116M -213M -14.63B -218M -1.43B -565M -7.01B -585M -573M -24.87B |
| Net Debt | -139M -119M -109M -103M -190M -13.06B -195M -1.28B -504M -6.26B -522M -512M -22.2B | -168M -143M -131M -124M -229M -15.72B -234M -1.54B -607M -7.53B -629M -616M -26.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-22 | 28.83 $ | +0.17% | 322,694 |
| 26-04-21 | 28.78 $ | -4.29% | 1,062,600 |
| 26-04-20 | 30.07 $ | -1.67% | 573,262 |
| 26-04-17 | 30.58 $ | +0.07% | 1,040,439 |
| 26-04-16 | 30.56 $ | +0.46% | 1,379,934 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MLYS Stock
Select your edition
All financial news and data tailored to specific country editions

















